MiR-125a-5p inhibits the proliferation and invasion of breast cancer cells and induces apoptosis by targeting GAB2

Li-Bing Wang; Liang Feng; Jing He; Bo Liu; Jian-Guang Sun; Li-Bing Wang; Liang Feng; Jing He; Bo Liu; Jian-Guang Sun

doi:10.3934/mbe.2019347

Mathematical Biosciences and Engineering

2019, Volume 16, Issue 6: 6923-6933. doi: 10.3934/mbe.2019347

Previous Article Next Article

Research article Special Issues

MiR-125a-5p inhibits the proliferation and invasion of breast cancer cells and induces apoptosis by targeting GAB2

1.
Department of Thyroid and Breast Surgery, The First Hospital of Shijiazhuang, Shijiazhuang 050011, Hebei, China;
2.
Department of General Surgery, People's Hospital of Haiyan, Jiaxing 314300, Zhejiang, China

Received: 28 February 2019 Accepted: 10 July 2019 Published: 30 July 2019

To investigate whether miR-125a-5p can inhibit the proliferation and invasion of breast cancer cells and induce apoptosis by targeting GAB2. Methods: qRT-PCR was used to detect the expression of miR-125a-5p in normal mammary epithelial cells and breast cancer cell lines; The miR-125a-5p overexpression plasmid was transiently transfected into MDA-MB-157 cells, and the proliferation, invasion and apoptosis of breast cancer cells were detected by CCK8 kit, Transwell chamber and flow cytometry, respectively; Gene silencing was used to knock down GAB2 gene in MDA-MB-157 cells, and the changes of proliferation, invasion, apoptosis and apoptosis-related proteins in breast cancer cells were detected by CCK8 kit, Transwell chamber, flow cytometry and western blot, respectively; The direct interaction between miR-125a-5p and GAB2 was detected by dual-luciferase reporter assay. The miR-125a-5p overexpression plasmid was transiently transfected into MDA-MB-157 cells, and the expression levels of GAB2 and apoptosis-related proteins were detected by western blot. Results: The expression of miR-125a-5p in breast cancer cell lines, MDA-MB-157 cells, MDA-MB-361 cells and MDA-MB-415 cells, was significantly lower than that in normal breast epithelial cells, MCF-10A cells; The proliferation and invasion ability of MDA-MB-157 cells transfected with miR-125a-5p were significantly inhibited, and the apoptosis rate was significantly increased; Since GAB2 knocked down, the proliferation and invasion ability of MDA-MB-157 cells were significantly inhibited, while the apoptosis rate was significantly increased, the Bax protein expression was significantly down-regulated, and the Bcl-2 protein expression was significantly up-regulated; The dual-luciferase reporter assay demonstrated that miR-125a-5p can specifically target GAB2. Transfected with miR-125a-5p, the GAB2 protein expression and Bax protein expression were significantly down-regulated, but the Bcl-2 protein expression was significantly up-regulated. Conclusion: miR-125a-5p inhibits the proliferation and invasion of breast cancer cells and induces their apoptosis by negatively regulating GAB2.
- Breast cancer,
- miR-125a-5p,
- GAB2,
- proliferation,
- invasion,
- apoptosis
Citation: Li-Bing Wang, Liang Feng, Jing He, Bo Liu, Jian-Guang Sun. MiR-125a-5p inhibits the proliferation and invasion of breast cancer cells and induces apoptosis by targeting GAB2[J]. Mathematical Biosciences and Engineering, 2019, 16(6): 6923-6933. doi: 10.3934/mbe.2019347

Related Papers:

Abstract

To investigate whether miR-125a-5p can inhibit the proliferation and invasion of breast cancer cells and induce apoptosis by targeting GAB2. Methods: qRT-PCR was used to detect the expression of miR-125a-5p in normal mammary epithelial cells and breast cancer cell lines; The miR-125a-5p overexpression plasmid was transiently transfected into MDA-MB-157 cells, and the proliferation, invasion and apoptosis of breast cancer cells were detected by CCK8 kit, Transwell chamber and flow cytometry, respectively; Gene silencing was used to knock down GAB2 gene in MDA-MB-157 cells, and the changes of proliferation, invasion, apoptosis and apoptosis-related proteins in breast cancer cells were detected by CCK8 kit, Transwell chamber, flow cytometry and western blot, respectively; The direct interaction between miR-125a-5p and GAB2 was detected by dual-luciferase reporter assay. The miR-125a-5p overexpression plasmid was transiently transfected into MDA-MB-157 cells, and the expression levels of GAB2 and apoptosis-related proteins were detected by western blot. Results: The expression of miR-125a-5p in breast cancer cell lines, MDA-MB-157 cells, MDA-MB-361 cells and MDA-MB-415 cells, was significantly lower than that in normal breast epithelial cells, MCF-10A cells; The proliferation and invasion ability of MDA-MB-157 cells transfected with miR-125a-5p were significantly inhibited, and the apoptosis rate was significantly increased; Since GAB2 knocked down, the proliferation and invasion ability of MDA-MB-157 cells were significantly inhibited, while the apoptosis rate was significantly increased, the Bax protein expression was significantly down-regulated, and the Bcl-2 protein expression was significantly up-regulated; The dual-luciferase reporter assay demonstrated that miR-125a-5p can specifically target GAB2. Transfected with miR-125a-5p, the GAB2 protein expression and Bax protein expression were significantly down-regulated, but the Bcl-2 protein expression was significantly up-regulated. Conclusion: miR-125a-5p inhibits the proliferation and invasion of breast cancer cells and induces their apoptosis by negatively regulating GAB2.

References

[1]	W. Chen, R. Zheng, P. D. Baade, et al., Cancer statistics in China, 2015, CA-Cancer J. Clin., 66 (2016), 115–132.
[2]	R. L. Siegel, K. D. Miller and A. Jemal, Cancer Statistics, 2017, CA-Cancer J. Clin., 67 (2017), 7–30.
[3]	E. Dirican and M. Akkiprik, Phosphatidylinositol 3-kinase regulatory subunit 1 and phosphatase and tensin homolog as therapeutic targets in breast cancer, Tumour Biol., 39 (2017), 1010428317695529.
[4]	S. Nagini, Breast cancer: Current molecular therapeutic targets and new players, Anticancer Agents Med. Chem., 17 (2017), 152–163.
[5]	M. Untch, G. E. Konecny, S. Paepke, et al., Current and future role of neoadjuvant therapy for breast cancer, Breast, 23 (2014), 526–537.
[6]	R. J. Wang, Y. H. Zheng, P. Wang, et al., Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer, Int. J. Clin. Exp. Pathol., 8 (2015), 765–771.
[7]	H. He, F. Xu, W. Huang, et al., miR-125a-5p expression is associated with the age of breast cancer patients, Genet. Mol. Res., 14 (2015), 17927–17933.
[8]	Y. Xu, Z. Huang and Y. Liu, Reduced miR-125a-5p expression is associated with gastric carcinogenesis through the targeting of E2F3, Mol. Med. Rep., 10 (2014), 2601–2608.
[9]	K. Cao, Y. Fang, H. Wang, et al., The lncRNA HOXA11-AS regulates Rab3D expression by sponging miR-125a-5p promoting metastasis of osteosarcoma, Cancer Manag. Res., 11 (2019), 4505–4518.
[10]	L. Tang, L. Zhou, S. Wu, et al., miR-125a-5p inhibits colorectal cancer cell epithelial-mesenchymal transition, invasion and migration by targeting TAZ, Oncotargets Ther., 12 (2019), 3481–3489.
[11]	S. Wang, L. Ran, W. Zhang, et al., FOXS1 is regulated by GLI1 and miR-125a-5p and promotes cell proliferation and EMT in gastric cancer, Sci. Rep., 9 (2019), 5281.
[12]	Y. Chen, Q. Liu, M. Wu, et al., GAB2 promotes cell proliferation by activating the ERK signaling pathway in hepatocellular carcinoma, Tumour Biol., 37 (2016), 11763–11773.
[13]	C. B. Ding, W. N. Yu, J. H. Feng, et al., Structure and function of Gab2 and its role in cancer (Review), Mol. Med. Rep., 12 (2015), 4007–4014.
[14]	L. Sun, Y. Liu, X. Li, et al., Gab2-Akt-ARK5 signaling pathway is associated with the invasion of glioma cells, Chin. J. Clin. Onco., 41 (2014), 551–554.
[15]	X. W. Xu, P. R. Li, Z. S. Zhang, et al., miR-125a-5p inhibits the migration of breast cancer cells by targeting GAB2, Chin. J. Biochem. Mol. Biol., (2017).
[16]	X. J. Li, Z. F. Li, Y. Y. Xu, et al., microRNA-374 inhibits proliferation and promotes apoptosis of mouse melanoma cells by inactivating the Wnt signalling pathway through its effect on tyrosinase, J. Cell. Mol. Med., (2019).
[17]	T. Matsumura, K. Sugimachi, Y. Takahashi, et al., Clinical significance of GAB2, a scaffolding/docking protein acting downstream of EGFR in human colorectal cancer, Ann. Surg. Oncol., 21 Suppl 4 (2014), S743–749.
[18]	N. Leblanc, J. Harquail, N. Crapoulet, et al., Pax-5 inhibits breast cancer proliferation through MiR-215 up-regulation, Anticancer Res., 38 (2018), 5013–5026.
[19]	Y. Yang, D. P. Li, N. Shen, et al., TPX2 promotes migration and invasion of human breast cancer cells, Asian Pac. J. Trop. Med., 8 (2015), 1064–1070.
[20]	M. Frohlich, N. Schafer, M. Caspers, et al., Temporal phenotyping of circulating microparticles after trauma: a prospective cohort study, Scand. J. Trauma. Resusc. Emerg. Med., 26 (2018), 33.
[21]	C. Cedolini, S. Bertozzi, A. P. Londero, et al., Type of breast cancer diagnosis, screening, and survival, Clin. Breast Cancer, 14 (2014), 235–240.
[22]	S. J. Davis, K. E. Sheppard, M. S. Anglesio, et al., Enhanced GAB2 expression is associated with improved survival in high-grade serous ovarian cancer and sensitivity to PI3K inhibition, Mol. Cancer Ther., 14 (2015), 1495–1503.
[23]	S. Halbach, K. T. Rigbolt, F. U. Wohrle, et al., Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells, Cell. Commun. Signal, 11 (2013), 30.
[24]	X. L. Xu, X. Wang, Z. L. Chen, et al., Overexpression of Grb2-associated binder 2 in human lung cancer, Int. J. Biol. Sci., 7 (2011), 496–504.
[25]	D. Park, S. C. Lee, J. W. Park, et al., Overexpression of miR-17 in gastric cancer is correlated with proliferation-associated oncogene amplification, Pathol. Int., 64 (2014), 309–314.
[26]	Z. Cai, J. Li, Q. Zhuang, et al., MiR-125a-5p ameliorates monocrotaline-induced pulmonary arterial hypertension by targeting the TGF-β1 and IL-6/STAT3 signaling pathways, Exp. Mol. Med., 50 (2018), 45.
[27]	D. W. Melton, X. Lei, J. A. Gelfond, et al., Dynamic macrophage polarization-specific miRNA patterns reveal increased soluble VEGF receptor 1 by miR-125a-5p inhibition, Physiol. Genomics, 48 (2016), 345–360.
[28]	K. Odar, E. Bostjancic, N. Gale, et al., Differential expression of microRNAs miR-21, miR-31, miR-203, miR-125a-5p and miR-125b and proteins PTEN and p63 in verrucous carcinoma of the head and neck, Histopathology, 61 (2012), 257–265.

Reader Comments

Your name:*

Email:*
© 2019 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)